pharmaphorum

JULY 17, 2023

7 best practices for assessing eCOA technology solutions Mike.

96

96

Pharma Marketing Network

JULY 19, 2023

Sponsorships can be a powerful tool for pharmaceutical companies to engage with communities and make a positive impact on health and wellness. When done right, sponsorships can help pharmaceutical companies connect with their target audience, build relationships with key stakeholders, and promote their brand in a meaningful way. Here are some examples of how pharmaceutical companies can use sponsorships to engage communities: Sponsoring community health events: Pharmaceutical companies can s

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Vaccines Hospitals 98

Pharmacy Times

JULY 17, 2023

Every pharmacist can make a difference in patients’ lives by taking the time to understand and fulfill the community’s social and cultural needs.

Immunization 123

Immunization 123

Drug Topics

JULY 17, 2023

Methamphetamine deaths among American Indian and Native Alaskan men and women significantly increased between 1992 and 2019.

469

469

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

JULY 18, 2023

Over the last 5 years, both PBMs and drug manufacturers have implemented restrictions that raise patients’ cost burden for specialty medications.

Pharmaceutical Companies 466

Pharmaceutical Companies Pharmaceutical Companies 466

Hospital Pharmacy Europe

JULY 17, 2023

Immune checkpoint inhibitors have transformed the management of non-small cell lung cancer, but how long should treatment be continued for optimal survival? Rod Tucker takes a closer look at the evidence. It has long been recognised that a hallmark of cancer is immune evasion and that the immune system is held back by inhibitory immune checkpoint receptors and ligands.

Immunization 98

Immunization Hospitals FDA 98

Pharmacy Times

JULY 18, 2023

Study suggests supplemental oxygen may improve cognitive functions that are vital in motor learning, which can be important for people with neurological conditions or trauma.

123

123

Pharmacy Times

JULY 18, 2023

Therapeutic drug monitoring is a growing and vital area for pharmacists to become involved in to increase patient success with inflammatory bowel disease remission.

123

123

Fierce Healthcare

JULY 18, 2023

The Centers for Medicare & Medicaid Services (CMS) could remove PET scan restrictions to better determine whether patients qualify for new drugs and to shine light on whether a drug is slowing | CMS could remove PET scan restrictions that limit just one brain scan per clinical trial to better determine whether new Alzheimer's drugs are slowing cognitive decline.

98

98

Drug Topics

JULY 20, 2023

The FDA is working quickly to address shortages of the form used in nebulizers.

FDA 469

FDA 469

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

PharmaVoice

JULY 20, 2023

Peter Benton, co-CEO of Worldwide Clinical Trials, explains how the rise of the mid-sized pharma company has changed drug R&D.

246

246

PhRMA

JULY 20, 2023

Most insured Americans believe insurance should provide affordable access to health care (93%), but only a third (34%) say it does, according to the fourth installment of the Patient Experience Survey (PES). The survey — based on interviews with 5,000 Americans — explores this disconnect, detailing the challenges insured Americans face affording care and how practices by health insurers and middlemen put patient lifelines to access at risk.

Insurance 186

Insurance 186

Pharmacy Times

JULY 21, 2023

Quitting treatment may significantly improve severe hypertension in patients with hepatocellular carcinoma.

123

123

Drug Topics

JULY 19, 2023

Only 1 in 5 patients who initiated buprenorphine were retained in therapy for at least 180 days.

469

469

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

PharmaVoice

JULY 18, 2023

Meta’s new platform is drawing Twitter comparisons and could hold potential for pharma marketers in patient and HCP communication.

Communication 246

Communication 246

STAT

JULY 21, 2023

WASHINGTON – The White House on Friday launched its pandemic preparedness office, half a year after Congress instructed the administration to set up a new arm in the wake of the coronavirus pandemic. The Office of Pandemic Preparedness and Response Policy is a now-permanent installment in Washington and will first be led by retired Major General Paul Friedrichs, a longtime biosecurity official.

Packaging 98

Packaging 98

Pharmacy Times

JULY 21, 2023

A company’s choice of color for branding and logo design may impact how consumers feel about the brand and could influence buyer decision-making.

123

123

Drug Topics

JULY 18, 2023

The Drug Supply Chain Security Act has been a decade in the making. Pharmacists must be prepared to comply by November 2023.

469

469

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

PharmaVoice

JULY 19, 2023

Stevanato’s focus on biologic-related vials and delivery devices has put it in a unique position amid a quickly growing market.

242

242

STAT

JULY 21, 2023

Stanford President Marc Tessier-Lavigne , who will step down from his position Aug. 31, was initially accused of scientific misconduct, but that’s not why he lost his job. He lost it because he failed to adequately lead his labs, and because of the repercussions that failure had for his leadership of a premier research institution. In his own words, Tessier-Lavigne resigned because Stanford “needs a president whose leadership is not hampered” by discussions of problems with

98

98

Pharmacy Times

JULY 21, 2023

The research narrows the most at-risk populations and how to mitigate the impacts on adults with ADRD.

123

123

Drug Topics

JULY 18, 2023

Filling prescriptions is no longer a sufficient source of revenue for community pharmacy.

Community Pharmacies 469

Community Pharmacies 469

PharmaVoice

JULY 19, 2023

With AI expectations riding high, here’s a look at some areas where the technology could be most useful in drug development.

130

130

STAT

JULY 21, 2023

Significant challenges remain before most American clinicians feel comfortable treating patients with buprenorphine , according to a new study. While the federal government’s recent moves to deregulate buprenorphine have led to a bump in new prescribers, it didn’t lead to a significant bump in overall prescribing volume. Many health care providers still see prescribing buprenorphine as difficult, or simply have little interest in using the medication, according to the study.

98

98

Pharmacy Times

JULY 21, 2023

Individuals with age-related hearing loss should not be treated with “standard” hearing aids, but fitted to their personal needs, while avoiding settings that add distortion.

123

123

Drug Topics

JULY 17, 2023

A Q&A with Colin Banas, MD, chief medical officer at health care software company DrFirst.

469

469

PharmaVoice

JULY 18, 2023

A former WHO epidemiologist is applying lessons learned during the Ebola epidemic to her work leading a company at the forefront of women’s health: the reproductive microbiome.

130

130

STAT

JULY 21, 2023

In the wake of the Covid-19 pandemic, we’ve heard a lot about gain-of-function research, and some of its risks, particularly regarding the possible creation of dangerous pathogens. But there’s a lot more to this field than that, including research that could potentially be quite beneficial to human society. If we focus solely on the risks, we may miss those benefits.

98

98

Pharmacy Times

JULY 21, 2023

For adolescents and young adults affected by HIV, Google yielded higher quality information on pre-exposure prophylaxis more frequently compared to other search engines.

123

123

Drug Topics

JULY 21, 2023

Despite the increase in drug costs outpacing inflation, Pennsylvania seniors are still paying the same amount for prescriptions that they did in 1990.

467

467

PharmaVoice

JULY 17, 2023

A new toolkit developed by industry stakeholders paves the way for faster reviews.

130

130

STAT

JULY 21, 2023

Diagnostic errors — that is, overlooking a disease, or diagnosing it erroneously or late — are a known occurrence in health care, and one that can have tragic effects. Yet so far there have been few attempts to quantify misdiagnoses in terms of deaths and permanent disability, and the full scale of their impact has been underestimated by the medical community, according to a 2015 report by the National Academy of Medicine.

98

98

Pharmacy Times

JULY 20, 2023

Managing cost savings can soften the blow of direct and indirect remuneration fee reform that will impact pharmacists during the first half of 2024.

123

123